Institutions / Camber Capital Management LP
Camber Capital Management LP
CIK 1444043 · Institutionalso an insider · as of Jun 30, 2025
Portfolio value
$717.90M
Positions
23
As of
Jun 30, 2025
Portfolio trend
Portfolio value
$717.90M-55.2%Positions
23-17.9%Top holdings
Jun 30, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Zimmer Biomet Holdings, Inc.ZBH | $91.21M | 12.7% |
| Baxter International Inc.BAX | $86.30M | 12.0% |
| Humana IncHUM | $73.34M | 10.2% |
| CVS HEALTH CorpCVS | $72.43M | 10.1% |
| Globus Medical IncGMED | $47.22M | 6.6% |
| Icon Public Limited CompanyICLR | $43.63M | 6.1% |
| Ascendis Pharma A/S - AdrASND | $43.15M | 6.0% |
| Merck & Co., Inc.MRK | $39.58M | 5.5% |
| Pfizer IncPFE | $36.36M | 5.1% |
| Biomarin Pharmaceutical IncBMRN | $32.98M | 4.6% |
| Unitedhealth Group IncUNH | $31.20M | 4.3% |
| Viatris IncVTRS | $24.56M | 3.4% |
| Brookdale Senior Living Inc.BKD | $14.96M | 2.1% |
| ZimVie Inc.ZIMV | $14.96M | 2.1% |
| Apellis Pharmaceuticals, Inc.APLS | $14.71M | 2.0% |
| Myriad Genetics IncMYGN | $10.62M | 1.5% |
| Evolent Health IncEVH | $9.57M | 1.3% |
| Concentra Group Holdings Parent, Inc.CON | $8.23M | 1.1% |
| Inogen IncINGN | $6.85M | 1.0% |
| Denali Therapeutics IncDNLI | $5.60M | 0.8% |
| Theravance Biopharma, Inc.tbph | $4.96M | 0.7% |
| Anaptysbio, Inc.ANAB | $2.77M | 0.4% |
| Orasure Technologies IncOSUR | $2.70M | 0.4% |
Activity
Jun 30, 2025View full history →
InsidersInstitutions
This fund's quarter-over-quarter position changes — what it's buying and selling.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q1 2025 as of | Exit Other (per filing) | Medtronic plc common | $-219.67M | -2.8M -100.00% | 0 | high |
| Q2 2021 as of | Trim Other (per filing) | 15912K100 | $-205.06M | -8.9M -79.11% | 2,350,000 7.54% of portfolio | high |
| Q1 2021 as of | Exit Other (per filing) | 015351109 | $-183.58M | -1.2M -100.00% | 0 | high |
| Q2 2022 as of | Exit Other (per filing) | Gilead Sciences, Inc. common | $-148.63M |
Insider transactions
Also trades as an insider
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Aug 2, 2024 | Sell Open-market sale | ZIMV ZimVie Inc. Common Stock | $9.30M | -525K -16.15% | 2,725,000 | medium |